Abbvie Shared Detailed Results From The Multiple Ascending Dose Part Of Its Phase 1 Study Evaluating ABBV-295 At EASD Annual Meeting, Showing Favorable Tolerability And Pharmacokinetic Profile

뉴스 본문을 불러오고 있어요.

Abbvie Shared Detailed Results From The Multiple Ascending Dose Part Of Its Phase 1 Study Evaluating ABBV-295 At EASD Annual Meeting, Showing Favorable Tolerability And Pharmacokinetic Profile | 웨이프 WAPE

Abbvie Shared Detailed Results From The Multiple Ascending Dose Part Of Its Phase 1 Study Evaluating ABBV-295 At EASD Annual Meeting, Showing Favorable Tolerability And Pharmacokinetic Profile

기사 요약

관련 종목

댓글 —